Distribuzione geografica
Continente #
NA - Nord America 2218
EU - Europa 2090
AS - Asia 759
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 1
SA - Sud America 1
Totale 5077
Nazione #
US - Stati Uniti d'America 2217
IE - Irlanda 865
CN - Cina 627
UA - Ucraina 567
SE - Svezia 395
FI - Finlandia 131
IN - India 74
TR - Turchia 57
GB - Regno Unito 53
BE - Belgio 35
DE - Germania 21
EU - Europa 8
RU - Federazione Russa 8
IT - Italia 7
FR - Francia 4
CZ - Repubblica Ceca 2
AT - Austria 1
CA - Canada 1
IR - Iran 1
NZ - Nuova Zelanda 1
PL - Polonia 1
UY - Uruguay 1
Totale 5077
Città #
Dublin 865
Chandler 510
Jacksonville 407
Dearborn 285
Nyköping 263
Nanjing 220
Wilmington 93
Princeton 82
San Mateo 81
Beijing 75
Des Moines 75
Nanchang 73
Ann Arbor 71
Helsinki 50
Shenyang 40
Boardman 39
Woodbridge 39
Brussels 35
Hebei 33
Changsha 30
Kunming 30
Tianjin 24
Hangzhou 22
Jiaxing 22
Philadelphia 17
Hilden 14
Lanzhou 10
Zhengzhou 8
Jinan 7
Los Angeles 6
Changchun 5
Ningbo 5
Guangzhou 4
Foggia 3
Hefei 3
Norwalk 3
Orange 3
Shanghai 3
Auburn Hills 2
Borås 2
Fuzhou 2
Glasgow 2
Redwood City 2
Saint Petersburg 2
Stevenage 2
Wuhan 2
Ardabil 1
Caserta 1
Chaoyang 1
Edinburgh 1
Haikou 1
Harbin 1
Houston 1
Leicester 1
London 1
Montevideo 1
Mountain View 1
Owings Mills 1
Perugia 1
Pinehaven 1
Redmond 1
Rockville 1
Shaoxing 1
Taizhou 1
Vienna 1
Walnut 1
Warsaw 1
Totale 3592
Nome #
In siblings of celiac children, rectal gluten challenge reveals gluten sensitization not restricted to celiac HLA 122
Interleukin 15 mediates epithelial changes in celiac disease. 95
Severe clinical onset of diabetes and increased prevalence of other autoimmune diseases in children with coeliac disease diagnosed before diabetes mellitus. 90
Blockage of T-cell costimulation inhibits T-cell action in celiac disease. 86
A search for the holy grail: non-toxic gluten for celiac patients 82
Analysis of lactase processing in rabbit. 81
Gluten-sensitive disease with mild enteropathy 81
Celiac disease: In vitro and in vivo safety and palatability of wheat-free sorghum food products. 79
Patchy expression of lactase protein in adult rabbit and rat intestine 79
Mannan and oligomers of N-acetylglucosamine protect intestinal mucosa of celiac patients with active disease from in vitro toxicity of gliadin peptides. 76
Celiac disease: a model autoimmune disease with gene therapy applications 75
Imaging active lymphocytic infiltration in coeliac disease with iodine-123-interleukin-2 and the response to diet. 75
Effects of gluten enriched diet on the small intestinal mucosa of normal mice and mice with graft versus host reaction. 75
Prevention by mannan and other sugars of in vitro damage of rat fetal small intestine induced by cereal prolamin peptides toxic for human celiac intestine. 74
High incidence of spontaneous autoimmune thyroiditis in immunocompetent self-reactive human T cell receptor transgenic mice 73
A y(+)LAT-1 mutant protein interferes with y(+)LAT-2 activity: implications for the molecular pathogenesis of lysinuric protein intolerance 73
Mosaic differentiation of human villus enterocytes: patchy expression of blood group A antigen in A nonsecretors. 72
Amines protect in vitro the celiac small intestine from the damaging activity of gliadin peptides. 72
In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa. 71
Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia. 71
Choroid plexus carcinoma in a child: a case report 71
Unconjugated bilirubin modulates the intestinal epithelial barrier function in a human-derived in vitro model 70
Cutaneous manifestations as presenting sign of autoimmune lymphoproliferative syndrome in childhood 69
L-15 drives the specific migration of CD94+ and TCR-gammadelta+ intraepithelial lymphocytes in organ cultures of treated celiac patients. 69
Lactase persistence versus decline in human adults: multifactorial events are involved in down-regulation after weaning. 69
Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization. 68
Gliadin as stimulator adaptive and innate immune responses in celiac disease. 68
Malignant extradural spinal cord compression in childhood: diagnostic, surgical, and prognostic considerations with respect to 6 cases 67
Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa. 66
Immunologic and intestinal permeability tests as predictors of relapse during gluten challenge in childhood coeliac disease. 66
Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. 65
Surface staining on the villus of lactase protein and lactase activity in adult-type hypolactasia. 65
The lipid A of Burkholderia multivorans C1576 smooth-type lipopolysaccharide and its pro-inflammatory activity in a cystic fibrosis airways model 64
Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. 64
Cellular basis of adult-type hypolactasia 64
Endomysial antibodies as unreliable markers for slight dietary transgressions in adolescents with celiac disease. 63
Reactive nitrogen species modulate the effects of rhein, an active component of senna laxatives, on human epithelium in vitro 63
Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients. 62
DNA fragmentation is a feature of cystic fibrosis epithelial cells: a disease with inappropriate apoptosis? 62
Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis 60
Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease 60
Cytotoxic effect of prolamin-derived peptides on in vitro cultures of cell line Caco-2: Implications for coeliac disease. 60
In vitro biosynthesis of lactase in preweaning and adult rabbit. 59
Efficacy of budesonide therapy in the early phase of treatment of adult celiac disease patients with malabsorption: An in vivo/in vitro pilot study 59
Degenerate self-reactive human T-cell receptor causes spontaneous autoimmune disease in mice 59
Cranial metastases of neuroblastoma of unusual size 59
Cellular basis of adult-type hypolactasia. 58
Morphological method for the diagnosis of human adult type hypolactasia. 58
Mosaic regulation of lactase in human adult-type hypolactasia 58
Gluten sensitive disease with mild enteropathy 58
Intestinal mucosa of celiacs in remission is unable to abolish toxicity of gliadin peptides on in vitro developing fetal rat intestine and cultured atrophic celiac mucosa. 57
Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease. 57
Unexpected role of surface transglutaminase type II in celiac disease 56
Evidence of still-ongoing convergence evolution of the lactase persistence T-13910 alleles in humans. 56
Celiac Disease: a common food intolerance on an immunological basis 56
Cellular basis of adult-type hypolactasia 55
Gliadin as a stimulator of innate responses in celiac disease 54
Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure (vol 120, pg 203, 2010) 54
In vitro biosynthesis of lactase in suckling and adult rabbits. Regulatory mechanisms involved in the decline of the lactase activity. 54
Cystic fibrosis: a disorder with defective autophagy 53
Cerebral artery aneurysms in childhood 53
Diagnostic morphological methods: Use of immunomorphological and enzymo-histochemical methods for a single disease entity 53
Sturge-Weber disease without facial nevus 52
Is there a direct specific cytotoxic effect of gliadin on the intestinal mucosa in celiac disease? 51
In vitro biosynthesis of lactase proteins in human small intestinal tissues with persistent high lactase activity and with adult-type hypolactasia 51
Headache in pediatric patients with celiac disease and its prevalence as a diagnostic clue 50
FAS engagement drives apoptosis of enterocytes of coeliac patients. 50
Plexiform neurofibroma of the occipital scalp 49
In vitro organ culture system 49
Giant spinal lipoma extending into the posterior fossa in a 6 months old child 48
Vertebral osteoid osteoma, rare cause of nerve root compression and scoliosis in childhood 48
Introduction to oxidative stress and antioxidant therapy 48
The human adult-type hypolactasia is a heterogeneous condition in in vitro biosynthetic studies 47
Mucosal cell-mediated immunity in Coeliac Disease 47
Epilepsy caused by vascular insufficiency as a result of a malformation in a child 45
Intracranial germinomas: two cases with review of the literature 45
In vitro gluten challenge 45
Semilobar holoprosencephaly: embryologic, CSF dynamics and radiological considerations. 43
Lactase activity of the enterocytes of human proximal jejunum with adult-type hypolactasia 42
Guidelines for the use and interpretation of assays for monitoring autophagy 42
Nebulized Hyaluronan Ameliorates lung inflammation in cystic fibrosis mice 40
The lipid A of Burkholderia multivorans C1576 smooth-type lipopolysaccharide and its pro-inflammatory activity in a cystic fibrosis airways model. 37
Totale 5092
Categoria #
all - tutte 13312
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13312

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20185 0000 00 00 0005
2018/2019506 01052 96140 1160 8174864
2019/20201173 2741451823 148148 1958 10517857
2020/2021575 860787 8252 894 828951
2021/2022397 901104 265 1034 413615125
2022/20232118 18789140133 113187 64145 100916350
Totale 5092